Hot off the breath: Mortality as a primary end-point in IPF treatment trials: The best is the enemy of the good

Hot off the breath: Mortality as a primary end-point in IPF treatment trials: The best is the enemy of the good / A.U. Wells, J. Behr, U. Costabel, V. Cottin, V. Poletti, L. Richeldi, C. Albera, J. Ancochea, K.M. Antoniou, P. Bonella, D. Bouros, P. Bresser, J.F. Cordier, B. Crestani, J. Domagala-Kulawik, M. Drent, J.J. Egan, T. Geiser, J. Grunewald, J. Grutters, G. Gudmundsson, A. Guenther, S. Harari, N.K. Harrison, N. Hirani, U. Hodgson, C.M. Kahler, M.P. Keane, G. Kiter, M. Kneussl, T.M. Maher, N. Mogulkoc, J. Muller-Quernheim, C. Neurohr, H. Nunes, H. Parfrey, T. Peros-Golubicic, V. Polychronopoulos, G. Prevot, E.R. Renzoni, C. Robalo Cordeiro, C. Saltini, M. Skold, P. Spagnolo, M. Thomeer, S. Tomasseti, D. Valeyre, C. Vancheri, B. Wallaert, W. Wuyts, A. Xaubet. - In: THORAX. - ISSN 0040-6376. - 67:11(2012), pp. 938-940. [10.1136/thoraxjnl-2012-202580]